From: Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
BDP/F extrafine pMDI (n = 53)
BUD/F and FP/S DPI (n = 58)
All (n = 111)
Controlled
30 (56.60%)*
21 (36.21%)
51 (45.94%)
Partially controlled
17 (32.08%)
26 (44.83%)
43 (38.74%)
Uncontrolled
6 (11.32%)
11 (18.96%)
17 (15.32%)